Dr. Leila Catherine Onbargi is an American gynecologist based in Barcelona. She earned her medical degree from the Feinberg School of Medicine (Northwestern University) and completed her residency in obstetrics and gynecology at Prentice Women’s Hospital (Northwestern University), both located in Chicago.

She has been board-certified by the American Board of Obstetrics and Gynecology (ABOG) since 1995 and is a member of the American College of Obstetrics and Gynecology (ACOG), as well as various renowned American and Spanish medical associations.

Dr. Onbargi brings her top-tier training from a leading U.S. hospital along with extensive experience in private practice to offer highly professional and personalized care to her patients in her office at the Cliníca Teknon in Barcelona.

Our practice provides comprehensive gynecological care, including:

• Specialized care during the menopause
• General gynecology and annual exams
• Family planning and contraception
• Regenerative gynecology

As the population ages, more women are going through the menopause transition. Dr. Onbargi is a certified specialist by the Menopause Society (MS) in the United States, the International Menopause Society (IMS), and the Spanish Association for the Study of Menopause (AEEM). We offer patients updated, safe, evidence-based guidance and recommendations to address the most common physical and emotional symptoms of menopause using both natural therapies and bioidentical hormones when appropriate, always tailoring the treatment to each patient’s individual risk profile and preference.

In gynecology, we stay up to date with the latest developments by attending international meetings and regularly reviewing the most relevant scientific publications in our field. We incorporate the latest treatments for many common gynecological conditions, next-generation contraceptives, advances in infertility treatments, and address the growing demand for regenerative gynecology, which includes treatments to restore pelvic floor anatomy and function.

To reinforce our commitment in preventive medicine, we promote screening programs for not only the early detection of breast, uterine, cervical, and ovarian cancer , but also the diagnosis and monitoring of non-gynecological conditions that affect women's health, such as depression, osteoporosis, cardiovascular health, and cognitive decline.

New genetic testing is now available to evaluate personal risks for certain cancers and diseases, enabling a more personalized and effective approach.

*Patients covered by standard insurance policies are not accepted; only private patients or those with reimbursement-based insurance plans are treated.